Li, H, Engel, C, de la Hoya, M, Peterlongo, P, Yannoukakos, D, Livraghi, L, Radice, P, Thomassen, M, Hansen, T V O, Gerdes, A-M, Nielsen, H R, Caputo, S M, Zambelli, A, Borg, A, Solano, A, Thomas, A, Parsons, M T, Antoniou, A C, Leslie, G, Yang, X, Chenevix-Trench, G, Caldes, T, Kwong, A, Pedersen, I S, Lautrup, C K, John, E M, Terry, M B, Hopper, J L, Southey, M C, Andrulis, I L, Tischkowitz, M, Janavicius, R, Boonen, S E, Kroeldrup, L, Varesco, L, Hamann, U, Vega, A, Palmero, E I, Garber, J, Montagna, M, Van Asperen, C J, Foretova, L, Greene, M H, Selkirk, T, Moller, P, Toland, A E, Domchek, S M, James, P A, Thorne, H, Eccles, D M, Nielsen, S M, Manoukian, S, Pasini, B, Caligo, M A, Lazaro, C, Kirk, J, Wappenschmidt, B, Spurdle, A B, Couch, F J, Schmutzler, R, Goldgar, D E, ENIGMA consortium & CIMBA Consortium 2022, ' Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants ', Genetics in Medicine, vol. 24, no. 1, pp. 119-129 . https://doi.org/10.1016/j.gim.2021.08.016 Genet Med Genetics in Medicine, 24(1), 119-129. ELSEVIER SCIENCE INC ENIGMA Consortium 2022, ' Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants ', Genetics in Medicine, vol. 24, no. 1, pp. 119-129 . https://doi.org/10.1016/j.gim.2021.08.016 Goldgar, D E, ENIGMA Consortium & CIMBA Consortium 2022, ' Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants ', Genetics in Medicine, vol. 24, no. 1, pp. 119-129 . https://doi.org/10.1016/j.gim.2021.08.016